[Form 4] CLARIVATE PLC Insider Trading Activity

Rhea-AI Filing Summary

Mourad Maroun S., a director and President, IP of Clarivate plc (CLVT), reported insider acquisitions on 09/15/2025. The filing shows 539,568 ordinary shares acquired directly at a reported price of $0, and 105,000 ordinary shares held indirectly by spouse. No derivative securities were reported. The form was signed by an attorney-in-fact on 09/16/2025.

Positive

• Insider transparency: Reporting person filed required Section 16 Form 4 detailing transactions.
• Substantial direct acquisition: 539,568 ordinary shares were reported acquired, increasing disclosed insider ownership.
• Indirect holdings disclosed: 105,000 ordinary shares reported as beneficially owned by spouse.

Negative

• None.

Insights

Financial Analyst

TL;DR: Significant direct share acquisition reported by a senior officer; price reported as $0 and additional shares held indirectly by spouse.

The transaction shows a large direct increase of 539,568 ordinary shares and 105,000 indirectly beneficially owned shares via spouse. The reported price is $0, which is an explicit fact in the filing; the form contains no earnings, valuation context, or cash consideration details. For investors, this is a material insider ownership change to note alongside other disclosures.

Corporate Governance Expert

TL;DR: Director/officer disclosed substantial beneficial ownership change; filing complies with Section 16 reporting requirements.

The report identifies the reporting person as a director and officer and records both direct and indirect holdings. The filing includes no derivative transactions and is signed by an attorney-in-fact. This is a routine Section 16 disclosure of insider ownership change rather than a corporate governance action.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mourad Maroun S.

(Last) (First) (Middle)

C/O CLARIVATE PLC

70 ST. MARY AXE

(Street)

LONDON X0 EC3A 8BE

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
CLARIVATE PLC [ CLVT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President, IP

3. Date of Earliest Transaction (Month/Day/Year)
09/15/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Ordinary Shares	09/15/2025		A		539,568	A	$0	539,568	D
Ordinary Shares								105,000	I	By spouse

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

	/s/ John Doulamis, Attorney-in-Fact	09/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Mourad Maroun S. report on Form 4 for CLVT?

He reported acquiring 539,568 ordinary shares directly on 09/15/2025 and 105,000 shares indirectly beneficially owned by his spouse.

What price was reported for the shares acquired in the CLVT Form 4?

The filing reports a price of $0 for the 539,568 ordinary shares acquired.

Were any derivative securities reported in this CLVT Form 4?

No derivative securities were reported; Table II shows no entries.

What is Mourad Maroun S.'s relationship to Clarivate plc in this filing?

He is identified as a Director and an Officer (President, IP).

When was the transaction and when was the Form 4 signed?

Transaction date: 09/15/2025. Form signed by attorney-in-fact on 09/16/2025.